Phase 0 testing

Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps
Endpoints
Tue, 08/27/19 - 09:55 am
Bristol-Myers Squibb
Celgene
Presage Biosciences
Phase 0 testing
drug development